Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,710,496
-$22,135 QoQ
Shares Held
69,482
-22.0% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#151
of 772 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $463,988,771 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,252,140 | $305,558,778 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,356,009 | $45,941,583 | |
| 3 | HLN |
Haleon plc
|
3,095,451 | $28,880,557 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,674,005 | $26,834,300 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
707,194 | $17,404,044 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
29,023 | $15,725,531 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
69,482 | $11,710,496 | |
| 8 | VTRS |
Viatris Inc
|
644,514 | $10,234,881 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,710,496 | 69,482 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,732,631 | 89,059 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,073,703 | 85,128 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,349,716 | 95,097 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,556,169 | 107,854 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,852,136 | 89,079 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,749,918 | 93,406 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $9,630,317 | 83,582 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $13,246,469 | 96,219 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $12,722,154 | 92,243 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $852,618 | 6,471 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $851,512 | 7,569 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $853,226 | 9,048 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,010,782 | 9,986 | Shares | Defined | 2023-05-03 | |
| 2021-06-30 | $11,035,114 | 113,390 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $10,167,681 | 104,552 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $9,970,508 | 104,022 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $8,388,324 | 87,233 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,846,566 | 97,103 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $6,296,425 | 72,749 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||